Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

New test for often-fatal osophageal disorder of dogs
German shepherds are predisposed to congential idiopathic megaesophagus.

Test predicts the risk of congenital idiopathic megaesophagus with 75 per cent accuracy.

Researchers in the US have developed a genetic test for an often-fatal osophageal disorder of German shepherd dogs.

German shepherds are prone to an inherited condition called congenital idiopathic megaesophagus (CIM), in which a puppy develops an enlarged oesophagus making it difficult to pass food into the stomach. The condition causes regurgitation and failure to thrive in puppies shortly after weaning.

While German shepherds are predisposed to CIM, Labrador retrievers, dachshunds, Great Danes, and miniature schnauzers are also prone to the disease. However, scientists do not yet understand whether the same genetic variation is involved.

In the study, researchers at Clemson University, South Carolina, performed a genome-wide scan to identify genes associated with the disorder.

The scan revealed an association on canine chromosome 12 and a variant within melanin-concentrating hormone receptor two (MCHR2) that affects appetite, weight and how food moves through the gastrointestinal tract. The team believes that an imbalance of melanin-concentrating hormones plays a role in CIM.

Researchers also discovered that male puppies are twice as likely to be affected by CIM than females. This finding suggests that higher estrogen levels allow food to pass to the stomach more effectively, thus protecting against disease development.

“What they’ve found in people is that estrogen has the effect of relaxing the sphincter that connects the esophagus to the stomach,” commented Sarah Bell, a graduate research assistant in genetics and the first author of the study. 

“By having more estrogen, the smooth muscle there is naturally more likely to open. This increases the motility of food into the stomach. In dogs with megaesophagus disease, a drug called sildenafil has shown good results. What it does is to relax the sphincter that connects the esophagus and stomach.” 

In light of their findings, researchers have developed a genetic test that predicts whether a dog will develop CIM with 75 per cent accuracy. After swabbing their dog’s gums, owners can submit the sample to genetic testing companies to learn which variant(s) their dog inherited. 

Scientists hope the tool will help breeders reduce the risk that puppies in future litters will develop the disease. 

“One thing I stress with any disease in any breed is don’t make a problem where there isn’t one,” said Bell. “If you’ve been breeding German shepherds for 20 years and you’ve never bred a megaesophagus puppy, then don’t use this test,” she said. “But if you’re a breeder and you’ve had megaesophagus puppies, you may benefit from the test.”

The findings are published in the journal PLOS Genetics.

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
CMA to host webinar exploring provisional decisions

The Competition and Markets Authority (CMA) is to host a webinar for veterinary professionals to explain the details of its provisional decisions, released on 15 October 2025.

The webinar will take place on Wednesday, 29 October 2025 from 1.00pm to 2.00pm.

Officials will discuss the changes which those in practice may need to make if the provisional remedies go ahead. They will also share what happens next with the investigation.

The CMA will be answering questions from the main parties of the investigation, as well as other questions submitted ahead of the webinar.

Attendees can register here before Wednesday, 29 October at 11am. Questions must be submitted before 10am on 27 October.

A recording of the webinar will be accessible after the event.